Y Intercept Hong Kong Ltd Sells 7,841 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Y Intercept Hong Kong Ltd significantly reduced its holdings in UnitedHealth Group by 92.8%, now owning just 611 shares valued at approximately $320,000.
• Multiple large investors increased their positions in UnitedHealth Group, with GAMMA Investing LLC raising its stake by over 56,142%, now owning shares worth approximately $4.34 billion.
• UnitedHealth Group announced an increase in its quarterly dividend to $2.21 per share, with a current yield of 3.39% and a payout ratio of 37.02%.

Y Intercept Hong Kong Ltd cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 92.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 611 shares of the healthcare conglomerate's stock after selling 7,841 shares during the period. Y Intercept Hong Kong Ltd's holdings in UnitedHealth Group were worth $320,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter valued at about $30,000. Kapitalo Investimentos Ltda bought a new position in UnitedHealth Group in the 4th quarter valued at about $41,000. Finally, Copia Wealth Management bought a new position in UnitedHealth Group in the 4th quarter valued at about $42,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 4.9%

Shares of NYSE UNH traded down $12.16 during midday trading on Friday, hitting $237.40. 39,874,177 shares of the company traded hands, compared to its average volume of 15,268,949. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50-day moving average price of $296.86 and a 200 day moving average price of $416.24. The firm has a market cap of $215.36 billion, a P/E ratio of 10.29, a P/E/G ratio of 1.56 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.7%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director directly owned 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Mizuho dropped their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Royal Bank Of Canada reduced their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday. Finally, Piper Sandler reduced their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $373.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.